Trial intelligence / Profile preview

Erdosteine for bronchiectasis in children and young adults

ACTRN12621000315819Phase 4Recruiting

Sponsor
Queensland University of Technology
Start
May 2021
Modality
Small Molecules
Countries
3
01

Overview

Phase 4 trial of erdosteine, sponsored by Queensland University of Technology. Started May 2021; status: recruiting.

02

Drugs

erdosteine

Beyond the preview

Go deeper on ACTRN12621000315819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621000315819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call